These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 1944245
1. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity. Chae K, Gibson MK, Korach KS. Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245 [Abstract] [Full Text] [Related]
2. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site. Korach KS, Chae K, Levy LA, Duax WL, Sarver PJ. J Biol Chem; 1989 Apr 05; 264(10):5642-7. PubMed ID: 2925625 [Abstract] [Full Text] [Related]
3. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites. Metzger DA, Curtis S, Korach KS. Endocrinology; 1991 Apr 05; 128(4):1785-91. PubMed ID: 2004602 [Abstract] [Full Text] [Related]
4. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites. Chae K, Johnston SH, Korach KS. J Steroid Biochem Mol Biol; 1991 Jan 05; 38(1):35-42. PubMed ID: 1997122 [Abstract] [Full Text] [Related]
5. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity. Duax WL, Swenson DC, Strong PD, Korach KS, McLachlan J, Metzler M. Mol Pharmacol; 1984 Nov 05; 26(3):520-5. PubMed ID: 6548545 [Abstract] [Full Text] [Related]
6. Estrogen receptor stereochemistry: receptor binding and hormonal responses. Korach KS, Levy LA, Sarver PJ. J Steroid Biochem; 1987 Nov 05; 27(1-3):281-90. PubMed ID: 3695485 [Abstract] [Full Text] [Related]
7. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation. Kohno H, Bocchinfuso WP, Gandini O, Curtis SW, Korach KS. J Mol Endocrinol; 1996 Jun 05; 16(3):277-85. PubMed ID: 8782086 [Abstract] [Full Text] [Related]
8. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity. Murphy CS, Parker CJ, McCague R, Jordan VC. Mol Pharmacol; 1991 Mar 05; 39(3):421-8. PubMed ID: 2005879 [Abstract] [Full Text] [Related]
9. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Toxicol Appl Pharmacol; 1997 Jul 05; 145(1):111-23. PubMed ID: 9221830 [Abstract] [Full Text] [Related]
10. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness. Korach KS, Chae K, Gibson M, Curtis S. Steroids; 1991 May 05; 56(5):263-70. PubMed ID: 1877066 [Abstract] [Full Text] [Related]
11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA. Toxic Rep Ser; 1999 Aug 05; (59):1-66, A1-E7. PubMed ID: 11803702 [Abstract] [Full Text] [Related]
12. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol. Sato T, Ohta Y, Okamura H, Hayashi S, Iguchi T. Anat Rec; 1996 Mar 05; 244(3):374-85. PubMed ID: 8742702 [Abstract] [Full Text] [Related]
13. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone. Mobbs BG, Johnson IE, DeSombre ER, Toth J, Hughes A. Cancer Res; 1987 May 15; 47(10):2645-51. PubMed ID: 3552202 [Abstract] [Full Text] [Related]
14. Estrogen receptor residues required for stereospecific ligand recognition and activation. Bocchinfuso WP, Korach KS. Mol Endocrinol; 1997 May 15; 11(5):587-94. PubMed ID: 9139802 [Abstract] [Full Text] [Related]
15. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. J Med Chem; 1999 Jul 01; 42(13):2456-68. PubMed ID: 10395487 [Abstract] [Full Text] [Related]
16. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators. Guo ZR, Yi X, Xu ZB. Acta Pharmacol Sin; 2002 Mar 01; 23(3):208-12. PubMed ID: 11918843 [Abstract] [Full Text] [Related]
17. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH. J Med Chem; 2004 Feb 12; 47(4):1018-30. PubMed ID: 14761204 [Abstract] [Full Text] [Related]
18. Diethylstilbestrol metabolites and analogs. Biochemical probes for differential stimulation of uterine estrogen responses. Korach KS, Fox-Davies C, Quarmby VE, Swaisgood MH. J Biol Chem; 1985 Dec 15; 260(29):15420-6. PubMed ID: 4066677 [Abstract] [Full Text] [Related]